If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
260.00    -5.00 (-1.84%)
Bid:
255.00
Ask:
265.00
Spread: 10.00 (3.922%)
Market Cap: £242.55m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Trading Update

20 Jan 2026 07:00

RNS Number : 5087P
Concurrent Technologies PLC
20 January 2026
 

 20 January 2026

 

 

Concurrent Technologies Plc

("Concurrent", the "Company" or the "Group")

 

Trading Update

 

Significant year-on-year growth driven by record order intake

 

Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems, and mission-critical solutions used in high-performance markets by some of the world's major OEMs, provides an update on trading for the year ended 31 December 2025 ("FY25").

 

Based on its unaudited management accounts, the Company expects both revenue and profit before tax to be in line with market expectations, delivering strong double-digit growth on FY24 (FY24: revenue £40.3m and profit before tax £5.2m).1 This reflects the growing momentum across the Group's Products and Systems business units, notwithstanding delays to US Department of Defense budget approvals and the recent US government shutdown.

 

Total order intake for FY25 was at a record level of approximately £47 million (FY24: £41 million), driven by particularly strong demand from customers in Europe and Asia-Pacific, reflecting the continued strengthening of Concurrent's reputation among leading global primes. The Group ended FY25 in a solid financial position with £14.4m of cash at bank (FY24: £13.7m), with elevated year-end debtors reflecting seasonally high invoicing.

 

In September, the Company announced a $5.2 million design services contract with a major defence prime contractor. A subsequent $1.0 million contract expansion has increased the total value to $6.2 million, making it Concurrent's largest single order to date. The expanded scope includes the design and supply of Automatic Test Equipment to support the customer's in-house production and testing, highlighting the early commercial success and growth potential of Concurrent's design services offering.

 

Outlook

The Company has entered the new financial year with good momentum, underpinned by robust customer demand, record order intake and a growing pipeline of design wins expected to convert into production revenues. This progress is supported by a solid balance sheet, providing the financial flexibility to continue investing as the Group delivers on its growth strategy in the year ahead, with strategic plans in place to manage component costs through the year as necessary.

 

Miles Adcock, CEO, commented: "FY25 was another strong year for Concurrent, in which we continued to execute on our stated strategy, as planned. With our new Los Angeles facilities now fully operational and the Colchester relocation expected to complete in H1 FY26, we believe the business is entering a new phase of operational capacity. We will see prior design wins begin translating into meaningful orders, while strengthening and diversifying our portfolio of products and services to support long-term growth. I am extremely proud of what our team has achieved and am excited by the scale of opportunity ahead."

 

1 As at 19 January 2026, The Board understands that market expectations for FY2025, based on published analyst forecasts, are for revenue of £46.0m, and profit before tax of £6.2m.

 

Enquiries:

Concurrent Technologies PlcMiles Adcock - CEO

Kim Garrod - CFO

 

 

 

+44 (0)1206 752626

Alma Strategic CommunicationsHannah Campbell

Josh Royston

Will Merison

 

 

+44 (0)20 3405 0205

Cavendish Capital Markets Limited (NOMAD)Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded plug-in cards and systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded operating systems. The products are sold world-wide.

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLMLTMTJBBTF
Date   Source Headline
25th Mar 20147:00 amRNSFinal Results
19th Mar 201412:36 pmRNSNotice of Results
17th Feb 20144:18 pmRNSHolding(s) in Company
27th Dec 20137:00 amRNSTrading Update
13th Dec 20134:31 pmRNSProduct Launch
6th Dec 20131:35 pmRNSHolding(s) in Company
28th Nov 201311:31 amRNSHolding(s) in Company
1st Nov 20133:45 pmRNSTotal Voting Rights
24th Oct 20134:13 pmRNSProduct Launch
23rd Oct 20132:56 pmRNSTransaction in Own Shares
8th Oct 20132:35 pmRNSProduct Launch
4th Oct 20135:01 pmRNSTransaction in Own Shares
1st Oct 20133:13 pmRNSTotal Voting Rights
25th Sep 20132:38 pmRNSTransaction in Own Shares
4th Sep 20132:42 pmRNSTransaction in Own Shares
22nd Aug 20137:00 amRNSInterim Results
16th Aug 20133:58 pmRNSNotice of Results
12th Aug 201312:40 pmRNSTrading Update
21st Jun 201312:20 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSProduct Launch
28th May 20132:00 pmRNSAGM Statement
24th May 20133:10 pmRNSProduct Launch
13th May 20134:25 pmRNSProduct Launch
24th Apr 20135:01 pmRNSDistribution of Annual Report and Accounts
9th Apr 20137:00 amRNSFinal Results
19th Mar 20134:25 pmRNSNotice of Results & Dividend
1st Mar 20132:15 pmRNSProduct Launch
24th Dec 20127:00 amRNSTrading Update
21st Dec 20121:17 pmRNSProduct Launch
21st Nov 20123:27 pmRNSHolding(s) in Company
5th Nov 201212:25 pmRNSProduct Launch
31st Oct 201210:32 amRNSTotal Voting Rights
19th Sep 20125:28 pmRNSHolding(s) in Company
5th Sep 20127:00 amRNSInterim Results
29th Aug 20125:36 pmRNSNotice of Results
22nd Jun 20124:42 pmRNSTotal Voting Rights
14th Jun 20123:50 pmRNSTransaction in Own Shares
7th Jun 20127:00 amRNSProduct Launch
31st May 20123:30 pmRNSTotal Voting Rights
29th May 20121:30 pmRNSAGM Statement
22nd May 201212:21 pmRNSTreasury Shares
8th May 20127:00 amRNSDistribution of Annual Report and Accounts
4th May 20123:53 pmRNSHolding(s) in Company
17th Apr 20123:51 pmRNSHolding(s) in Company
12th Apr 201211:44 amRNSHolding(s) in Company
26th Mar 20127:00 amRNSPreliminary Results
16th Mar 20123:17 pmRNSNotice of Results
6th Mar 20121:45 pmRNSDividend Declaration
16th Jan 20127:00 amRNSProduct Launch
29th Dec 20115:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.